Vis enkel innførsel

dc.contributor.authorKulle, Bettina
dc.contributor.authorStøer, Nathalie Charlotte
dc.contributor.authorMartinsen, Jan Ivar
dc.contributor.authorUrsin, Giske
dc.contributor.authorWeiderpass, Elisabete
dc.contributor.authorThoresen, G. Hege
dc.contributor.authorDebernard, Karen A. Boldingh
dc.contributor.authorKarlstad, Øystein
dc.contributor.authorPottegard, Anton
dc.contributor.authorFriis, Søren
dc.date.accessioned2022-07-26T06:39:59Z
dc.date.available2022-07-26T06:39:59Z
dc.date.created2019-06-20T15:24:29Z
dc.date.issued2019
dc.identifier.citationBMJ Open. 2019, 9:e028504 (4), 1-7.
dc.identifier.issn2044-6055
dc.identifier.urihttps://hdl.handle.net/11250/3008459
dc.language.isoeng
dc.titleIdentification of potential carcinogenic and chemopreventive effects of prescription drugs: A protocol for a Norwegian registry-based study
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber1-7
dc.source.volume9:e028504
dc.source.journalBMJ Open
dc.source.issue4
dc.identifier.doi10.1136/bmjopen-2018-028504
dc.identifier.cristin1706528
cristin.unitcode7502,3,2,0
cristin.unitnameAvdeling for kroniske sykdommer og aldring
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel